These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26162977)
1. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977 [TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting. Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence. Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160 [TBL] [Abstract][Full Text] [Related]
5. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations. Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815 [TBL] [Abstract][Full Text] [Related]
7. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Chen Y; Pan L; Jiang M; Li D; Jin L Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035 [TBL] [Abstract][Full Text] [Related]
9. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894 [TBL] [Abstract][Full Text] [Related]
10. Modified Ce/Zr-MOF Nanoparticles Loaded with Curcumin for Alzheimer's Disease via Multifunctional Modulation. Yang Y; Wang Y; Jiang X; Mi J; Ge D; Tong Y; Zhu Y Int J Nanomedicine; 2024; 19():9943-9959. PubMed ID: 39355653 [TBL] [Abstract][Full Text] [Related]
11. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery. Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers. Wang F; Chen J; Dai W; He Z; Zhai D; Chen W Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Jiang H; Geng D; Liu H; Li Z; Cao J Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102 [TBL] [Abstract][Full Text] [Related]
14. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258 [TBL] [Abstract][Full Text] [Related]
15. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy. Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074 [TBL] [Abstract][Full Text] [Related]
16. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
17. Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine. Zhao C; Zhang J; Hu H; Qiao M; Chen D; Zhao X; Yang C Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1031-1040. PubMed ID: 30184727 [TBL] [Abstract][Full Text] [Related]
18. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405 [TBL] [Abstract][Full Text] [Related]
19. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061 [TBL] [Abstract][Full Text] [Related]